These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21374636)

  • 1. Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood?
    van Lith JM; Benacerraf BR; Yagel S
    Prenat Diagn; 2011 Mar; 31(3):231-4. PubMed ID: 21374636
    [No Abstract]   [Full Text] [Related]  

  • 2. From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood.
    Bianchi DW
    Prenat Diagn; 2010 Jul; 30(7):622-3. PubMed ID: 20572102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sounding board. First trimester Down syndrome screening in France].
    Simon-Bouy B; Royère D; Levy P
    Rev Prat; 2012 Dec; 62(10):1340-4. PubMed ID: 23424907
    [No Abstract]   [Full Text] [Related]  

  • 4. Down's Syndrome screening: confusion or consensus?
    Goldberg JD
    BJOG; 2004 Jun; 111(6):517-8. PubMed ID: 15198776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 6. Second trimester prenatal ultrasound and screening for Down syndrome.
    Benn PA; Egan JF
    Prenat Diagn; 2007 Sep; 27(9):884. PubMed ID: 17724762
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current controversies in prenatal diagnosis 1: is stem cell therapy ready for human fetuses?
    Mummery C; Westgren M; Sermon K
    Prenat Diagn; 2011 Mar; 31(3):228-30. PubMed ID: 21374635
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which prenatal screening protocol?
    Ferguson-Smith MA
    Prenat Diagn; 2004 Oct; 24(10):761. PubMed ID: 15503274
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple-marker screening for Down syndrome.
    Viner G
    CMAJ; 1996 Aug; 155(3):272; author reply 272-3. PubMed ID: 8705902
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple-marker screening for Down syndrome.
    Farrell SA; Chadwick DE; Summers AM; Wyatt PR
    CMAJ; 1996 Aug; 155(3):271-2; author reply 272-3. PubMed ID: 8705901
    [No Abstract]   [Full Text] [Related]  

  • 15. Current techniques of prenatal screening for Down syndrome.
    Cardwell MS; Gay JW
    Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Down syndrome screening paradigms.
    Caughey AB; Kaimal AJ; Odibo AO
    Clin Lab Med; 2010 Sep; 30(3):629-42. PubMed ID: 20638577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 19. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolving prenatal screening scene.
    Reddy UM
    Obstet Gynecol; 2007 Jul; 110(1):2-4. PubMed ID: 17601887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.